Menu Back to 8th-European-Forum-for-Qualified-Person-for-Pharmacovigilance-QPPV-and-Pre-conference-Workshop

Program Committee

  • Peter  De Veene, MD
    Peter De Veene, MD Executive Director, Clinical Safety and Pharmacovigilance
    Daiichi Sankyo Pharmaceuticals, United Kingdom
  • Margaret Anne Walters
    Margaret Anne Walters Director & Deputy EU Qualified Person for Pharmacovigilance
    Merck Sharp & Dohme Ltd., United Kingdom
  • Elspeth  McIntosh
    Elspeth McIntosh Director
    Castle Pharmacovigilance Ltd, United Kingdom
  • Doris Irene Stenver, MD, MPA
    Doris Irene Stenver, MD, MPA Chief Medical Officer
    Danish Health and Medicines Authority, Denmark
  • Vicki  Edwards, RPh
    Vicki Edwards, RPh QPPV and Head of Affiliate Vigilance Excellence
    AbbVie Ltd., United Kingdom
  • Michael  Richardson, MD, FFPM
    Michael Richardson, MD, FFPM International Head GPV&E and EU QPPV
    Bristol-Myers Squibb, United Kingdom
  • Brian David Edwards, MD, MRCP
    Brian David Edwards, MD, MRCP Vice President, ACRES; Principal Consultant, Pharmacovigilance and Drug Safety
    NDA Regulatory Science Ltd., United Kingdom
  • Natalia  Kocankova, MD, MBA
    Natalia Kocankova, MD, MBA Head of Pharmacovigilance
    Boehringer Ingelheim RCV GmbH & Co KG , Austria
Load More